screen_shot_2014-03-07_at_08

Novasep adds chairman role to its chief executive



pharmafile | March 7, 2014 | Appointment | Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Novasep, spagnol 

Life sciences manufacturing firm Novasep has appointed Michel Spagnol as chairman of its supervisory 
board following the departure of the group’s founder Roger-Marc Nicoud.

Spagnol joined Novasep as its chief executive in June 2013 and has overseen many people moves since then, such as Christian
Thiry as chief financial officer, Thierry Van Nieuwenhove as president of
its synthesis business unit and the promotion of Nadege Laborde as president
of its industrial biotech business.

 

“I thank Roger Marc for his never-ending enthusiasm and contribution to the
group’s development and I have profound respect for what he has achieved,”
said Spagnol.

Advertisement

Nicoud added: “Since October 2012, as chairman of Novaseps supervisory board, I have
assisted the executive management team in order to ensure that my succession
proceeds in the best possible conditions.” 

Related Content

AZ image

AstraZeneca sets up production unit in Africa

AstraZeneca is embarking upon a joint venture that will involve the building of a new …

lonza image

Lonza earmarks $15m for ADC plant expansion

Swiss contract manufacturer Lonza has said it will invest around 14 million francs ($15m) in …

Novasep invest €30m in ‘world’s largest chromatography plant’

French purification specialist Novasep has said it plans to invest €30 million in a new …

The Gateway to Local Adoption Series

Latest content